Hankang Capital

Hankang capital email format

Verified email-pattern data for Hankang Capital is currently limited. You can still use the company insights and contact sections below.
Hankang Capital focuses on the in-depth research in major diseases and unmet clinical needs, promoting the establishment of startups with first-tier teams and technology platforms. Hankang also provides professional insights, experience, and resources in product pipelines, team formation, application for registration, and clinical trials, to promote the startups becoming an industry leader. Since the establishment of the company,Hankang has invested in Eastern Biotech, Innocare, Abbisko Therapeutics, Teligene Ltd, Chipscreen, Akeso Biopharma, LP Pharma,Wuhan Hiteck(code: 300683),etc which are the leaders in the industry. Hankang Capital was awarded‘Top 100 Venture Capital Institutions’and‘Top 20 Investment Institutions in the Healthcare Sector’issued by Zero2IPO Group

Company Details

Employees
8
Founded
-
Address
Room 6002, No.555, Haiyangxi Road, Shanghai,china
Industry
Venture Capital And Private Equity Principals
HQ
Shanghai
Looking for a particular Hankang Capital employee's phone or email?

Hankang Capital Questions

Explore related pages

Related company profiles:

Top Hankang Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant